SANUWAVE Health, Inc 8-K, filed Dec 22, 2022
SANUWAVE Health, Inc. (SNWV)
8-K
2022-12-22
For: 2022-12-19
View Original
Added on
April 10, 2026
About this 8-K
SANUWAVE Health, Inc filed this 8-K on December 22, 2022, reporting on events of December 19, 2022.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported)
|
|
||
|
|
|||
|
(Exact name of registrant as specified in its charter)
|
|||
|
|
|
|
|
|
(State or other jurisdiction
of incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
||
|
(Address of principal executive offices)
|
(Zip Code)
|
||
|
Registrant’s telephone number, including area code
|
(
|
||
|
N/A
|
|||
|
(Former name or former address, if changed since last report)
|
|||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
|
|
|
N/A
|
Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act. ☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
On November 18, 2022, SANUWAVE Health, Inc. (the “Company”) commenced the solicitation of written consents (the “Consent Solicitation”) from its stockholders with respect to the following proposals, which were approved on December 20, 2022:
Proposal 1. To approve an amendment to the Company’s Articles of Incorporation to effect a reverse stock split of the Company’s common
stock, par value $0.001 (the “Common Stock”), at a reverse stock split ratio ranging from any whole number between 1-for-50 and 1-for-100, subject to and as determined by
the Board of Directors.
|
Votes For
|
Votes Against
|
Abstain
|
Broker Non-Votes
|
|
306,476,740
|
11,981,209
|
958,156
|
0
|
Proposal 2. To approve an amendment to the Company’s
Articles of Incorporation to increase the number of authorized shares of Common Stock from 800,000,000 to 2,500,000,000.
|
Votes For
|
Votes Against
|
Abstain
|
Broker Non-Votes
|
|
294,922,676
|
23,364,904
|
1,128,525
|
0
|
Both proposals, which are described in more detail in the Company’s definitive proxy statement for the Consent Solicitation filed with the Securities and Exchange Commission on November 18, 2022 (the
“Proxy Statement”), received the affirmative requisite vote of the stockholders of the Company. The Consent Solicitation automatically terminated on December 20, 2022 in accordance with its terms, which are more fully described in the Proxy
Statement.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: December 22, 2022
|
SANUWAVE HEALTH, INC.
|
|
|
|
|
|
By: /s/ Toni Rinow
|
|
|
Toni Rinow
|
|
|
Chief Financial Officer
|